569 related articles for article (PubMed ID: 33291114)
1. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
3.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
Wang N; Fang JY
Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
8. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
11.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
Abu-Ghazaleh N; Chua WJ; Gopalan V
J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of Intestinal
Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
[TBL] [Abstract][Full Text] [Related]
14.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
15. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
[TBL] [Abstract][Full Text] [Related]
16. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
[TBL] [Abstract][Full Text] [Related]
18. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium and Enterobacteriaceae: important players for CRC?
Allen-Vercoe E; Jobin C
Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
[TBL] [Abstract][Full Text] [Related]
20. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
